Search research articles
Contact Us
Filters
Showing results (1-10 of 20) with videos related to
Page
of 2
Sort By:
Current Opinion in Nephrology and Hypertension
|
December 29, 2000
Angiotensin-converting enzyme gene polymorphisms in renal disease: clinically relevant?
M W Taal
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation
|
December 1, 2001
Achieving maximal renal protection in nondiabetic chronic renal disease
M W Taal, B M Brenner
Kidney International
|
May 3, 2000
Renoprotective benefits of RAS inhibition: from ACEI to angiotensin II antagonists
M W Taal, B M Brenner
Journal of Human Hypertension
|
March 17, 1999
ACE-I vs angiotensin II receptor antagonists: prevention of renal injury in chronic rat models
M W Taal, B M Brenner
Kidney International
|
March 7, 2008
Renal risk scores: progress and prospects
M W Taal, B M Brenner
Current Opinion in Nephrology and Hypertension
|
July 18, 2001
Evolving strategies for renoprotection: non-diabetic chronic renal disease
M W Taal, B M Brenner
Kidney International
|
September 14, 2006
Predicting initiation and progression of chronic kidney disease: Developing renal risk scores
M W Taal, B M Brenner
South African Medical Journal = Suid-Afrikaanse Tydskrif Vir Geneeskunde
|
August 5, 2000
Hepatitis C virus infection in chronic haemodialysis patients--relationship to blood transfusions and dialyser re-use
M W Taal, R van Zyl-Smit
South African Medical Journal = Suid-Afrikaanse Tydskrif Vir Geneeskunde
|
June 14, 2001
Cost-effectiveness of hepatitis B vaccination in haemodialysis patients
M W Taal, R van Zyl-Smit
Current Opinion in Nephrology and Hypertension
|
November 14, 2001
Pathogenesis of diabetic nephropathy: focus on transforming growth factor-beta and connective tissue growth factor
O V Sakharova, M W Taal, B M Brenner
Page
of 2
Search research articles
Search
Showing results (1-10 of 20) with videos related to
Sort By:
Page
of 2
Current Opinion in Nephrology and Hypertension
|
December 29, 2000
Angiotensin-converting enzyme gene polymorphisms in renal disease: clinically relevant?
M W Taal
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation
|
December 1, 2001
Achieving maximal renal protection in nondiabetic chronic renal disease
M W Taal, B M Brenner
Kidney International
|
May 3, 2000
Renoprotective benefits of RAS inhibition: from ACEI to angiotensin II antagonists
M W Taal, B M Brenner
Journal of Human Hypertension
|
March 17, 1999
ACE-I vs angiotensin II receptor antagonists: prevention of renal injury in chronic rat models
M W Taal, B M Brenner
Kidney International
|
March 7, 2008
Renal risk scores: progress and prospects
M W Taal, B M Brenner
Current Opinion in Nephrology and Hypertension
|
July 18, 2001
Evolving strategies for renoprotection: non-diabetic chronic renal disease
M W Taal, B M Brenner
Kidney International
|
September 14, 2006
Predicting initiation and progression of chronic kidney disease: Developing renal risk scores
M W Taal, B M Brenner
South African Medical Journal = Suid-Afrikaanse Tydskrif Vir Geneeskunde
|
August 5, 2000
Hepatitis C virus infection in chronic haemodialysis patients--relationship to blood transfusions and dialyser re-use
M W Taal, R van Zyl-Smit
South African Medical Journal = Suid-Afrikaanse Tydskrif Vir Geneeskunde
|
June 14, 2001
Cost-effectiveness of hepatitis B vaccination in haemodialysis patients
M W Taal, R van Zyl-Smit
Current Opinion in Nephrology and Hypertension
|
November 14, 2001
Pathogenesis of diabetic nephropathy: focus on transforming growth factor-beta and connective tissue growth factor
O V Sakharova, M W Taal, B M Brenner
Page
of 2